Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis

被引：0
|
作者：
Keiichiro Mori
Hadi Mostafaei
Noriyoshi Miura
Pierre I. Karakiewicz
Stefano Luzzago
Manuela Schmidinger
Andreas Bruchbacher
Benjamin Pradere
Shin Egawa
Shahrokh F. Shariat
机构：
[1] Medical University of Vienna,Department of Urology
[2] The Jikei University School of Medicine,Department of Urology
[3] Tabriz University of Medical Sciences,Research Center for Evidence Based Medicine
[4] Ehime University Graduate School of Medicine,Department of Urology
[5] University of Montreal Health Centre,Cancer Prognostics and Health Outcomes Unit
[6] European Institute of Oncology,Department of Urology
[7] IRCCS,Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center
[8] Medical University of Vienna,Department of Urology
[9] University Hospital of Tours,Division of Urology, Department of Special Surgery
[10] The University of Jordan,Department of Urology
[11] Weill Cornell Medical College,Department of Urology
[12] University of Texas Southwestern,Department of Urology, Second Faculty of Medicine
[13] Karl Landsteiner Institute of Urology and Andrology,Institute for Urology and Reproductive Health
[14] Charles University,undefined
[15] I.M. Sechenov First Moscow State Medical University,undefined
[16] European Association of Urology Research Foundation,undefined
[17] Université François Rabelais de Tours,undefined
[18] PRES Centre Val de Loire,undefined
来源：
Cancer Immunology, Immunotherapy | 2021年 / 70卷
关键词：
Renal cell carcinoma; Network meta-analysis; First-line; Immune-checkpoint inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 273
页数：8
相关论文
共 50 条
  • [1] Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis
    Mori, Keiichiro
    Mostafaei, Hadi
    Miura, Noriyoshi
    Karakiewicz, Pierre, I
    Luzzago, Stefano
    Schmidinger, Manuela
    Bruchbacher, Andreas
    Pradere, Benjamin
    Egawa, Shin
    Shariat, Shahrokh F.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (02) : 265 - 273
  • [2] First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Wallis, Christopher J. D.
    Klaassen, Zachary
    Bhindi, Bimal
    Ye, Xiang Y.
    Chandrasekar, Thenappan
    Farrell, Ann M.
    Goldberg, Hanan
    Boorjian, Stephen A.
    Leibovich, Bradley
    Kulkarni, Girish S.
    Shah, Prakesh S.
    Bjarnason, Georg A.
    Heng, Daniel Y. C.
    Satkunasivam, Raj
    Finelli, Antonio
    [J]. EUROPEAN UROLOGY, 2018, 74 (03) : 309 - 321
  • [3] Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Bosma, Nicholas A.
    Warkentin, Matthew T.
    Gan, Chun Loo
    Karim, Safiya
    Heng, Daniel Y. C.
    Brenner, Darren R.
    Lee-Ying, Richard M.
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2022, 37 : 14 - 26
  • [4] First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis
    Rousseau, Benoit
    Kempf, Emmanuelle
    Desamericq, Gaelle
    Boissier, Emilie
    Chaubet-Houdu, Marie
    Joly, Charlotte
    Saldana, Carolina
    Boussion, Helene
    Neuzillet, Cindy
    Macquin-Mavier, Isabelle
    Oudard, Stephane
    Salomon, Laurent
    de la Taille, Alexandre
    Tournigand, Christophe
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 107 : 44 - 53
  • [5] First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Hahn, Andrew W.
    Klaassen, Zachary
    Agarwal, Neeraj
    Haaland, Benjamin
    Esther, John
    Ye, Xiang Y.
    Wang, Xuechen
    Pal, Sumanta K.
    Wallis, Christopher J. D.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 708 - 715
  • [6] Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
    Cattrini, Carlo
    Messina, Carlo
    Airoldi, Chiara
    Buti, Sebastiano
    Roviello, Giandomenico
    Mennitto, Alessia
    Caffo, Orazio
    Gennari, Alessandra
    Bersanelli, Melissa
    [J]. THERAPEUTIC ADVANCES IN UROLOGY, 2021, 13
  • [7] First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis
    Aldin, Angela
    Besiroglu, Burcu
    Adams, Anne
    Monsef, Ina
    Piechotta, Vanessa
    Tomlinson, Eve
    Hornbach, Carolin
    Dressen, Nadine
    Goldkuhle, Marius
    Maisch, Philipp
    Dahm, Philipp
    Heidenreich, Axel
    Skoetz, Nicole
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (05):
  • [8] A systematic review and network meta-analysis of first-line treatment options in patients metastatic renal cell carcinoma
    Bin Riaz, Irbaz
    Ryu, Alexander J.
    Yao, Yuan
    Siddiqi, Rabbia
    Mathew, Jessey
    Sipra, Qurat Ul Ain Riaz
    Zahoor, Haris
    Wang, Zhen
    Murad, M. Hassan
    Pagliaro, Lance C.
    Costello, Brian Addis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma
    Bin Riaz, Irbaz
    He, Huan
    Ryu, Alexander J.
    Siddiqi, Rabbia
    Naqvi, Syed Arsalan Ahmed
    Yao, Yuan
    Husnain, Muhammad
    Narasimhulu, Deepa Maheswari
    Mathew, Jessey
    Sipra, Qurat Ul Ain Riaz
    Vandvik, Per Olav
    Joseph, Richard W.
    Liu, Hongfang
    Wang, Zhen
    Herasevich, Vitaly
    Singh, Parminder
    Hussain, Syed A.
    Ho, Thai H.
    Bryce, Alan H.
    Pagliaro, Lance C.
    Murad, Mohammad H.
    Costello, Brian A.
    [J]. EUROPEAN UROLOGY, 2021, 80 (06) : 712 - 723
  • [10] Systemic therapies for metastatic renal cell carcinoma in the second-line setting: A systematic review and network meta-analysis
    Liao, Yang
    Hou, Haifeng
    Han, Zhenhua
    Liu, Ying
    [J]. MEDICINE, 2022, 101 (37) : E30333
12345